Careers
Report side Effects
Sign in
about
Products
News
Manufacturing
Partnership
Contact Us
Oncology
IMATINIB MESYALATE
Brand Name
Veltero
Strength
3.5 mg
Dosage type
Injection
therapeutic area
Oncology
INDICATION
It is a proteasome inhibitor indicated for:
Treatment of adult patients with multiple myeloma
Treatment of adult patients with mantle cell lymphoma